Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 27 | 2022 | 1284 | 4.260 |
Why?
|
Premature Birth | 18 | 2023 | 1721 | 2.230 |
Why?
|
Pregnancy Rate | 15 | 2021 | 643 | 2.150 |
Why?
|
Gynecologic Surgical Procedures | 14 | 2021 | 336 | 2.080 |
Why?
|
Pregnancy Outcome | 28 | 2022 | 2795 | 2.000 |
Why?
|
Pregnancy | 136 | 2023 | 29144 | 1.930 |
Why?
|
Live Birth | 14 | 2023 | 512 | 1.850 |
Why?
|
Abortion, Induced | 6 | 2022 | 458 | 1.800 |
Why?
|
Infertility | 15 | 2023 | 655 | 1.600 |
Why?
|
Obstetrics | 14 | 2022 | 658 | 1.590 |
Why?
|
Placenta Diseases | 4 | 2022 | 199 | 1.570 |
Why?
|
Placenta | 11 | 2023 | 1698 | 1.540 |
Why?
|
Embryo Transfer | 10 | 2021 | 510 | 1.510 |
Why?
|
Gynecology | 11 | 2022 | 513 | 1.450 |
Why?
|
Pelvic Organ Prolapse | 12 | 2022 | 135 | 1.400 |
Why?
|
Preimplantation Diagnosis | 5 | 2023 | 151 | 1.220 |
Why?
|
Abortion, Legal | 2 | 2018 | 116 | 1.110 |
Why?
|
Cervix Uteri | 7 | 2021 | 590 | 1.080 |
Why?
|
Genital Neoplasms, Female | 5 | 2023 | 523 | 1.040 |
Why?
|
Maternal Age | 8 | 2022 | 802 | 1.040 |
Why?
|
Hemophilia A | 6 | 2007 | 351 | 0.940 |
Why?
|
Placenta Accreta | 4 | 2020 | 225 | 0.910 |
Why?
|
Costs and Cost Analysis | 2 | 2021 | 1681 | 0.880 |
Why?
|
Delivery, Obstetric | 12 | 2021 | 906 | 0.860 |
Why?
|
Female | 222 | 2024 | 380194 | 0.860 |
Why?
|
Oocyte Donation | 2 | 2019 | 49 | 0.860 |
Why?
|
Gestational Age | 15 | 2023 | 3493 | 0.820 |
Why?
|
Postpartum Hemorrhage | 3 | 2019 | 258 | 0.790 |
Why?
|
Suburethral Slings | 8 | 2020 | 76 | 0.780 |
Why?
|
Insurance | 1 | 2022 | 111 | 0.770 |
Why?
|
Placenta Previa | 2 | 2019 | 117 | 0.760 |
Why?
|
Pelvic Floor | 6 | 2021 | 138 | 0.730 |
Why?
|
Birth Rate | 7 | 2020 | 170 | 0.730 |
Why?
|
Contraception Behavior | 4 | 2014 | 185 | 0.720 |
Why?
|
Pre-Eclampsia | 10 | 2023 | 1200 | 0.710 |
Why?
|
Ultrasonography, Prenatal | 7 | 2023 | 1695 | 0.710 |
Why?
|
Reproductive Techniques, Assisted | 2 | 2023 | 482 | 0.700 |
Why?
|
Cesarean Section | 8 | 2021 | 1365 | 0.700 |
Why?
|
Pain, Postoperative | 7 | 2023 | 1643 | 0.690 |
Why?
|
Infant, Low Birth Weight | 5 | 2023 | 850 | 0.680 |
Why?
|
Humans | 245 | 2024 | 744343 | 0.660 |
Why?
|
Marijuana Smoking | 1 | 2022 | 253 | 0.650 |
Why?
|
Government Regulation | 2 | 2013 | 522 | 0.640 |
Why?
|
Counseling | 6 | 2023 | 1523 | 0.640 |
Why?
|
Pregnant Women | 2 | 2021 | 568 | 0.640 |
Why?
|
Blastocyst | 6 | 2020 | 424 | 0.610 |
Why?
|
Abortion, Spontaneous | 5 | 2023 | 544 | 0.590 |
Why?
|
Infant, Newborn | 40 | 2023 | 25625 | 0.590 |
Why?
|
Contraception | 4 | 2016 | 359 | 0.590 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2017 | 28 | 0.580 |
Why?
|
Intrauterine Devices, Copper | 1 | 2017 | 32 | 0.580 |
Why?
|
Levonorgestrel | 1 | 2017 | 77 | 0.570 |
Why?
|
Health Knowledge, Attitudes, Practice | 9 | 2018 | 3923 | 0.570 |
Why?
|
Research Report | 1 | 2020 | 355 | 0.570 |
Why?
|
Adult | 120 | 2023 | 214055 | 0.560 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3674 | 0.560 |
Why?
|
Infant Mortality | 3 | 2019 | 754 | 0.560 |
Why?
|
Ischemia | 3 | 2020 | 1907 | 0.560 |
Why?
|
Retrospective Studies | 66 | 2023 | 77449 | 0.550 |
Why?
|
Multiple Birth Offspring | 2 | 2012 | 21 | 0.550 |
Why?
|
Patient Dropouts | 1 | 2018 | 421 | 0.550 |
Why?
|
Community Health Centers | 4 | 2017 | 430 | 0.540 |
Why?
|
Patient Simulation | 4 | 2012 | 309 | 0.540 |
Why?
|
Health Services Accessibility | 5 | 2019 | 5137 | 0.530 |
Why?
|
Urination Disorders | 4 | 2020 | 241 | 0.530 |
Why?
|
Pregnancy, Unwanted | 2 | 2014 | 26 | 0.530 |
Why?
|
Cannabis | 1 | 2022 | 439 | 0.520 |
Why?
|
Congresses as Topic | 1 | 2020 | 764 | 0.510 |
Why?
|
After-Hours Care | 1 | 2016 | 102 | 0.510 |
Why?
|
Patient Care Team | 4 | 2020 | 2531 | 0.500 |
Why?
|
Streptococcus agalactiae | 2 | 2019 | 375 | 0.490 |
Why?
|
Endometrium | 1 | 2017 | 424 | 0.490 |
Why?
|
Health Personnel | 4 | 2016 | 3218 | 0.480 |
Why?
|
Obstetric Labor Complications | 2 | 2017 | 238 | 0.480 |
Why?
|
Health Status Disparities | 4 | 2019 | 1797 | 0.460 |
Why?
|
Leadership | 3 | 2017 | 1357 | 0.450 |
Why?
|
Pregnancy Complications | 11 | 2022 | 2861 | 0.440 |
Why?
|
Molecular Imaging | 1 | 2020 | 828 | 0.430 |
Why?
|
Aneuploidy | 6 | 2023 | 530 | 0.420 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2016 | 501 | 0.410 |
Why?
|
Pregnancy, Ectopic | 1 | 2013 | 141 | 0.410 |
Why?
|
Streptococcal Infections | 2 | 2019 | 638 | 0.410 |
Why?
|
Cross-Sectional Studies | 28 | 2024 | 25043 | 0.400 |
Why?
|
Congenital Abnormalities | 1 | 2016 | 707 | 0.400 |
Why?
|
Cardiotocography | 1 | 2011 | 23 | 0.400 |
Why?
|
Cosmetics | 2 | 2023 | 97 | 0.400 |
Why?
|
Heart Rate, Fetal | 1 | 2011 | 75 | 0.400 |
Why?
|
Urinary Bladder, Overactive | 2 | 2023 | 106 | 0.390 |
Why?
|
Patient Satisfaction | 6 | 2021 | 3396 | 0.390 |
Why?
|
Urinary Incontinence, Stress | 4 | 2016 | 183 | 0.390 |
Why?
|
Stress, Psychological | 5 | 2019 | 4245 | 0.390 |
Why?
|
Air Pollutants | 5 | 2023 | 2817 | 0.390 |
Why?
|
Pregnancy, Multiple | 3 | 2022 | 217 | 0.390 |
Why?
|
Depression | 6 | 2023 | 7766 | 0.380 |
Why?
|
Internet | 3 | 2022 | 3064 | 0.380 |
Why?
|
Maternal Exposure | 6 | 2023 | 961 | 0.370 |
Why?
|
Knowledge | 1 | 2012 | 181 | 0.370 |
Why?
|
Hemarthrosis | 2 | 2007 | 38 | 0.370 |
Why?
|
Ambulatory Care | 3 | 2020 | 2708 | 0.370 |
Why?
|
Social Class | 3 | 2018 | 1999 | 0.360 |
Why?
|
Infant, Small for Gestational Age | 4 | 2019 | 440 | 0.360 |
Why?
|
Clinical Competence | 8 | 2022 | 4687 | 0.360 |
Why?
|
United States | 29 | 2024 | 69872 | 0.360 |
Why?
|
Urination | 3 | 2016 | 204 | 0.350 |
Why?
|
Hypotension | 1 | 2016 | 884 | 0.350 |
Why?
|
Infertility, Female | 4 | 2021 | 787 | 0.350 |
Why?
|
Urinary Incontinence | 5 | 2019 | 496 | 0.350 |
Why?
|
Reproductive Medicine | 2 | 2022 | 108 | 0.350 |
Why?
|
Income | 2 | 2019 | 1913 | 0.340 |
Why?
|
MicroRNAs | 2 | 2022 | 3752 | 0.340 |
Why?
|
Laparoscopy | 8 | 2021 | 2151 | 0.330 |
Why?
|
Birth Weight | 9 | 2023 | 2069 | 0.330 |
Why?
|
Birth Order | 2 | 2019 | 95 | 0.330 |
Why?
|
Pregnancy Trimester, Second | 4 | 2016 | 732 | 0.320 |
Why?
|
Cohort Studies | 27 | 2023 | 40561 | 0.320 |
Why?
|
Referral and Consultation | 3 | 2022 | 3528 | 0.320 |
Why?
|
Hysterectomy | 5 | 2019 | 927 | 0.320 |
Why?
|
Ovulation Induction | 5 | 2021 | 274 | 0.310 |
Why?
|
Prenatal Diagnosis | 4 | 2020 | 1236 | 0.310 |
Why?
|
Placentation | 2 | 2019 | 82 | 0.310 |
Why?
|
Mothers | 7 | 2020 | 2165 | 0.310 |
Why?
|
Uterine Prolapse | 2 | 2021 | 73 | 0.300 |
Why?
|
Fetal Development | 5 | 2023 | 767 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2022 | 2020 | 0.290 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.290 |
Why?
|
Myofascial Pain Syndromes | 2 | 2019 | 35 | 0.290 |
Why?
|
Obstetric Labor, Premature | 2 | 2019 | 279 | 0.290 |
Why?
|
Attitude of Health Personnel | 4 | 2020 | 3843 | 0.280 |
Why?
|
Attitude to Health | 4 | 2018 | 2052 | 0.280 |
Why?
|
Solar Activity | 2 | 2023 | 37 | 0.280 |
Why?
|
Directive Counseling | 3 | 2020 | 166 | 0.280 |
Why?
|
Equipment Contamination | 1 | 2007 | 185 | 0.270 |
Why?
|
Fertility | 5 | 2023 | 781 | 0.270 |
Why?
|
Lead | 2 | 2022 | 852 | 0.270 |
Why?
|
Boston | 12 | 2021 | 9313 | 0.270 |
Why?
|
Cervical Length Measurement | 2 | 2016 | 41 | 0.260 |
Why?
|
Hemophilia B | 1 | 2006 | 81 | 0.260 |
Why?
|
Middle Aged | 56 | 2022 | 213383 | 0.260 |
Why?
|
Substance-Related Disorders | 1 | 2022 | 4258 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 4 | 2020 | 552 | 0.260 |
Why?
|
Prenatal Care | 3 | 2020 | 1092 | 0.260 |
Why?
|
Students, Medical | 2 | 2023 | 1862 | 0.260 |
Why?
|
Pregnancy Trimester, Third | 4 | 2020 | 571 | 0.260 |
Why?
|
Diabetes, Gestational | 3 | 2021 | 1184 | 0.260 |
Why?
|
Young Adult | 34 | 2022 | 56430 | 0.260 |
Why?
|
Teaching | 2 | 2015 | 1174 | 0.250 |
Why?
|
Joints | 1 | 2007 | 326 | 0.250 |
Why?
|
Ploidies | 3 | 2010 | 281 | 0.250 |
Why?
|
Cisplatin | 3 | 2020 | 1662 | 0.250 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2023 | 2408 | 0.250 |
Why?
|
Progesterone | 2 | 2021 | 776 | 0.250 |
Why?
|
Pelvic Pain | 2 | 2019 | 274 | 0.250 |
Why?
|
Health Care Surveys | 3 | 2013 | 2453 | 0.240 |
Why?
|
Mass Screening | 7 | 2022 | 5255 | 0.240 |
Why?
|
Hospitalization | 4 | 2021 | 10262 | 0.240 |
Why?
|
Fetal Blood | 3 | 2021 | 1318 | 0.240 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3966 | 0.240 |
Why?
|
Parity | 4 | 2022 | 929 | 0.240 |
Why?
|
Environmental Exposure | 2 | 2022 | 4234 | 0.240 |
Why?
|
Prospective Studies | 24 | 2023 | 53288 | 0.230 |
Why?
|
Cost of Illness | 4 | 2023 | 1859 | 0.230 |
Why?
|
House Calls | 2 | 2022 | 160 | 0.230 |
Why?
|
Botulinum Toxins, Type A | 2 | 2019 | 213 | 0.230 |
Why?
|
Quality Improvement | 5 | 2019 | 3749 | 0.230 |
Why?
|
Family Planning Services | 3 | 2014 | 263 | 0.220 |
Why?
|
Critical Illness | 1 | 2016 | 2670 | 0.220 |
Why?
|
Environmental Pollutants | 2 | 2022 | 1179 | 0.220 |
Why?
|
Case-Control Studies | 16 | 2022 | 21746 | 0.220 |
Why?
|
Placental Circulation | 2 | 2020 | 40 | 0.220 |
Why?
|
Social Stigma | 3 | 2019 | 701 | 0.220 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 933 | 0.210 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 514 | 0.210 |
Why?
|
Intensive Care Units | 1 | 2016 | 3679 | 0.210 |
Why?
|
Endometrial Hyperplasia | 1 | 2023 | 97 | 0.210 |
Why?
|
Anxiety | 5 | 2023 | 4297 | 0.210 |
Why?
|
Vagina | 4 | 2022 | 825 | 0.210 |
Why?
|
Odds Ratio | 6 | 2018 | 9849 | 0.210 |
Why?
|
Treatment Outcome | 25 | 2021 | 63114 | 0.210 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2021 | 2026 | 0.210 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2024 | 187 | 0.210 |
Why?
|
Infant | 15 | 2023 | 35136 | 0.210 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2019 | 489 | 0.210 |
Why?
|
Vaginal Neoplasms | 1 | 2022 | 106 | 0.210 |
Why?
|
Dystocia | 2 | 2012 | 34 | 0.200 |
Why?
|
Massachusetts | 10 | 2023 | 8663 | 0.200 |
Why?
|
Postpartum Period | 3 | 2023 | 1086 | 0.200 |
Why?
|
Resilience, Psychological | 2 | 2020 | 676 | 0.200 |
Why?
|
Genetic Testing | 6 | 2023 | 3444 | 0.200 |
Why?
|
Internship and Residency | 5 | 2022 | 5788 | 0.200 |
Why?
|
Oils | 1 | 2021 | 63 | 0.200 |
Why?
|
Cryopreservation | 3 | 2020 | 670 | 0.200 |
Why?
|
Hair Preparations | 1 | 2021 | 32 | 0.200 |
Why?
|
Surgical Instruments | 2 | 2018 | 395 | 0.200 |
Why?
|
Sepsis | 2 | 2014 | 2593 | 0.190 |
Why?
|
Incidence | 12 | 2021 | 20947 | 0.190 |
Why?
|
Insurance, Health | 4 | 2022 | 2494 | 0.190 |
Why?
|
Search Engine | 1 | 2022 | 144 | 0.190 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 188 | 0.190 |
Why?
|
Education, Medical | 2 | 2012 | 1721 | 0.190 |
Why?
|
Faculty, Medical | 3 | 2020 | 1181 | 0.190 |
Why?
|
Informed Consent | 2 | 2020 | 995 | 0.190 |
Why?
|
Embryo Implantation | 3 | 2013 | 272 | 0.190 |
Why?
|
Physical Examination | 1 | 2007 | 1237 | 0.190 |
Why?
|
Urinary Catheterization | 2 | 2019 | 202 | 0.190 |
Why?
|
Nuclear Medicine | 2 | 2020 | 233 | 0.190 |
Why?
|
DNA Methylation | 3 | 2020 | 4286 | 0.190 |
Why?
|
Teaching Materials | 1 | 2020 | 86 | 0.190 |
Why?
|
Male | 49 | 2024 | 350118 | 0.190 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2021 | 140 | 0.180 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2024 | 360 | 0.180 |
Why?
|
Placental Insufficiency | 1 | 2020 | 51 | 0.180 |
Why?
|
Labor, Induced | 2 | 2018 | 146 | 0.180 |
Why?
|
Anal Canal | 2 | 2021 | 376 | 0.180 |
Why?
|
Audiovisual Aids | 1 | 2020 | 92 | 0.180 |
Why?
|
Blood Coagulation Factors | 2 | 2001 | 355 | 0.180 |
Why?
|
Health Policy | 3 | 2022 | 2661 | 0.180 |
Why?
|
Infection Control | 1 | 2007 | 966 | 0.180 |
Why?
|
Shoulder | 2 | 2012 | 299 | 0.180 |
Why?
|
Diagnostic Techniques, Urological | 1 | 2019 | 28 | 0.180 |
Why?
|
Radioactivity | 1 | 2020 | 63 | 0.180 |
Why?
|
Phyllodes Tumor | 1 | 2019 | 53 | 0.180 |
Why?
|
Austria | 1 | 2020 | 203 | 0.170 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 128 | 0.170 |
Why?
|
Anti-Infective Agents, Urinary | 1 | 2019 | 28 | 0.170 |
Why?
|
Time Factors | 14 | 2021 | 40075 | 0.170 |
Why?
|
Colitis, Ulcerative | 3 | 2017 | 1912 | 0.170 |
Why?
|
Air Pollution | 2 | 2023 | 2286 | 0.170 |
Why?
|
Reproductive History | 1 | 2020 | 209 | 0.170 |
Why?
|
Pilot Projects | 9 | 2023 | 8324 | 0.170 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2021 | 454 | 0.170 |
Why?
|
International Agencies | 1 | 2020 | 240 | 0.170 |
Why?
|
Health Expenditures | 3 | 2023 | 2348 | 0.170 |
Why?
|
Urinary Retention | 3 | 2019 | 111 | 0.170 |
Why?
|
Prevalence | 10 | 2021 | 15226 | 0.170 |
Why?
|
Uterine Neoplasms | 2 | 2020 | 1513 | 0.170 |
Why?
|
Pericytes | 1 | 2021 | 292 | 0.170 |
Why?
|
Receptors, Glucocorticoid | 1 | 2020 | 302 | 0.170 |
Why?
|
Birth Intervals | 1 | 2018 | 51 | 0.160 |
Why?
|
Human papillomavirus 18 | 1 | 2019 | 128 | 0.160 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2020 | 282 | 0.160 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 528 | 0.160 |
Why?
|
Guideline Adherence | 3 | 2019 | 2266 | 0.160 |
Why?
|
Age Factors | 10 | 2019 | 18370 | 0.160 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 772 | 0.160 |
Why?
|
Antibodies, Viral | 4 | 2022 | 3176 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
Policy | 1 | 2022 | 508 | 0.160 |
Why?
|
Reproductive Health Services | 1 | 2019 | 80 | 0.160 |
Why?
|
Endocrine Disruptors | 1 | 2021 | 237 | 0.160 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2022 | 370 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3133 | 0.160 |
Why?
|
Oocytes | 2 | 2022 | 1187 | 0.160 |
Why?
|
Sperm Injections, Intracytoplasmic | 2 | 2016 | 160 | 0.160 |
Why?
|
Lymphopenia | 1 | 2020 | 285 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3240 | 0.160 |
Why?
|
Abdomen | 2 | 2014 | 1118 | 0.160 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 264 | 0.160 |
Why?
|
Particulate Matter | 4 | 2023 | 2530 | 0.160 |
Why?
|
Fellowships and Scholarships | 2 | 2018 | 1076 | 0.150 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2012 | 500 | 0.150 |
Why?
|
Intrauterine Device Expulsion | 1 | 2017 | 4 | 0.150 |
Why?
|
Human papillomavirus 16 | 1 | 2019 | 262 | 0.150 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 420 | 0.150 |
Why?
|
Phthalic Acids | 1 | 2022 | 436 | 0.150 |
Why?
|
Injections | 2 | 2019 | 840 | 0.150 |
Why?
|
Cyclophosphamide | 2 | 2020 | 2242 | 0.150 |
Why?
|
Hot Temperature | 1 | 2023 | 1354 | 0.150 |
Why?
|
Hypercalcemia | 1 | 2020 | 409 | 0.150 |
Why?
|
Nurse Practitioners | 2 | 2017 | 270 | 0.150 |
Why?
|
Radionuclide Imaging | 2 | 2020 | 2031 | 0.150 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2009 | 369 | 0.150 |
Why?
|
Single Embryo Transfer | 1 | 2016 | 29 | 0.150 |
Why?
|
Critical Pathways | 1 | 2021 | 476 | 0.140 |
Why?
|
Sex Reassignment Surgery | 1 | 2019 | 130 | 0.140 |
Why?
|
Postoperative Complications | 6 | 2021 | 15295 | 0.140 |
Why?
|
Papillomavirus Infections | 2 | 2021 | 1587 | 0.140 |
Why?
|
Citric Acid | 1 | 2017 | 126 | 0.140 |
Why?
|
Doxorubicin | 2 | 2020 | 2234 | 0.140 |
Why?
|
Carcinoma in Situ | 1 | 2022 | 806 | 0.140 |
Why?
|
Embryonic Development | 3 | 2010 | 711 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.140 |
Why?
|
Psychometrics | 1 | 2006 | 3002 | 0.140 |
Why?
|
Quinolines | 1 | 2021 | 732 | 0.140 |
Why?
|
Pessaries | 1 | 2016 | 17 | 0.140 |
Why?
|
Financing, Personal | 1 | 2019 | 308 | 0.140 |
Why?
|
Colorado | 2 | 2007 | 163 | 0.140 |
Why?
|
Enema | 1 | 2017 | 141 | 0.140 |
Why?
|
Communication | 4 | 2023 | 3749 | 0.140 |
Why?
|
Exercise Therapy | 2 | 2021 | 906 | 0.140 |
Why?
|
Postnatal Care | 2 | 2020 | 236 | 0.140 |
Why?
|
Cities | 1 | 2018 | 513 | 0.140 |
Why?
|
Neuromuscular Agents | 2 | 2019 | 134 | 0.140 |
Why?
|
Catheter-Related Infections | 1 | 2019 | 252 | 0.140 |
Why?
|
Urinary Tract Infections | 2 | 2019 | 788 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 412 | 0.140 |
Why?
|
Fibrinogen | 1 | 2019 | 894 | 0.140 |
Why?
|
Nicotine | 1 | 2021 | 681 | 0.140 |
Why?
|
Intrauterine Devices | 1 | 2017 | 122 | 0.140 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2017 | 91 | 0.140 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2019 | 333 | 0.140 |
Why?
|
Blood Glucose | 3 | 2021 | 6256 | 0.140 |
Why?
|
Insurance Coverage | 3 | 2023 | 1901 | 0.140 |
Why?
|
Telephone | 1 | 2019 | 617 | 0.140 |
Why?
|
Coercion | 1 | 2016 | 63 | 0.140 |
Why?
|
Scopolamine | 1 | 2016 | 99 | 0.140 |
Why?
|
Surgery, Plastic | 1 | 2022 | 624 | 0.140 |
Why?
|
Cathartics | 1 | 2017 | 125 | 0.140 |
Why?
|
Protein C | 2 | 2008 | 138 | 0.130 |
Why?
|
Telomere | 2 | 2018 | 910 | 0.130 |
Why?
|
Infant, Premature | 2 | 2022 | 2044 | 0.130 |
Why?
|
Muscarinic Antagonists | 1 | 2016 | 137 | 0.130 |
Why?
|
Language | 2 | 2023 | 1471 | 0.130 |
Why?
|
Urology | 1 | 2020 | 399 | 0.130 |
Why?
|
Vaginal Smears | 2 | 2015 | 511 | 0.130 |
Why?
|
Physicians | 4 | 2016 | 4567 | 0.130 |
Why?
|
Nitrogen Dioxide | 3 | 2023 | 490 | 0.130 |
Why?
|
Urinary Bladder Diseases | 1 | 2016 | 166 | 0.130 |
Why?
|
Chorionic Gonadotropin | 1 | 2017 | 477 | 0.130 |
Why?
|
BCG Vaccine | 1 | 2017 | 369 | 0.130 |
Why?
|
Treatment Refusal | 1 | 2018 | 421 | 0.130 |
Why?
|
Risk Management | 1 | 2018 | 571 | 0.120 |
Why?
|
Risk Factors | 19 | 2022 | 72290 | 0.120 |
Why?
|
Family Practice | 1 | 2017 | 516 | 0.120 |
Why?
|
Office Visits | 1 | 2019 | 598 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1836 | 0.120 |
Why?
|
Psychotropic Drugs | 1 | 2020 | 894 | 0.120 |
Why?
|
Clomiphene | 1 | 2014 | 72 | 0.120 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3647 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2019 | 752 | 0.120 |
Why?
|
Rape | 1 | 2015 | 133 | 0.120 |
Why?
|
Sex Offenses | 2 | 2015 | 354 | 0.120 |
Why?
|
DNA Helicases | 1 | 2020 | 859 | 0.120 |
Why?
|
Subcutaneous Tissue | 1 | 2014 | 135 | 0.120 |
Why?
|
Fertility Agents, Female | 1 | 2014 | 99 | 0.120 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 639 | 0.120 |
Why?
|
Emotions | 2 | 2023 | 2661 | 0.120 |
Why?
|
Depression, Postpartum | 2 | 2009 | 340 | 0.120 |
Why?
|
Parental Notification | 1 | 2013 | 12 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 522 | 0.120 |
Why?
|
Mycoplasma genitalium | 1 | 2013 | 10 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2018 | 599 | 0.120 |
Why?
|
Hospitals | 3 | 2017 | 3952 | 0.120 |
Why?
|
Insemination, Artificial | 1 | 2014 | 98 | 0.120 |
Why?
|
Lymph Node Excision | 2 | 2018 | 1261 | 0.120 |
Why?
|
Endometrial Neoplasms | 1 | 2023 | 1353 | 0.120 |
Why?
|
Stillbirth | 1 | 2016 | 346 | 0.120 |
Why?
|
Propensity Score | 1 | 2020 | 1781 | 0.120 |
Why?
|
Crohn Disease | 2 | 2017 | 2303 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11725 | 0.110 |
Why?
|
Colonic Pouches | 1 | 2014 | 121 | 0.110 |
Why?
|
Civil Rights | 1 | 2014 | 132 | 0.110 |
Why?
|
Third-Party Consent | 1 | 2013 | 64 | 0.110 |
Why?
|
Mycoplasma Infections | 1 | 2013 | 118 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 949 | 0.110 |
Why?
|
Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
Sex Factors | 6 | 2018 | 10397 | 0.110 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39050 | 0.110 |
Why?
|
Phosphates | 1 | 2017 | 786 | 0.110 |
Why?
|
Antithrombins | 2 | 2008 | 304 | 0.110 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.110 |
Why?
|
Religion | 1 | 2016 | 356 | 0.110 |
Why?
|
Pelvis | 1 | 2017 | 730 | 0.110 |
Why?
|
Abortion Applicants | 1 | 2012 | 6 | 0.110 |
Why?
|
Patient Compliance | 2 | 2016 | 2684 | 0.110 |
Why?
|
Longitudinal Ligaments | 1 | 2012 | 27 | 0.110 |
Why?
|
Adolescent | 18 | 2021 | 85781 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 2017 | 665 | 0.110 |
Why?
|
Postoperative Period | 4 | 2020 | 1842 | 0.110 |
Why?
|
Perioperative Care | 1 | 2020 | 1002 | 0.110 |
Why?
|
Models, Genetic | 2 | 2017 | 3494 | 0.110 |
Why?
|
Housing | 1 | 2017 | 664 | 0.110 |
Why?
|
Pain, Intractable | 1 | 2013 | 130 | 0.110 |
Why?
|
Infant, Premature, Diseases | 1 | 2018 | 706 | 0.110 |
Why?
|
Data Collection | 3 | 2023 | 3341 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.110 |
Why?
|
Puerperal Disorders | 1 | 2015 | 275 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2019 | 9239 | 0.100 |
Why?
|
Neoadjuvant Therapy | 2 | 2020 | 2728 | 0.100 |
Why?
|
Labor Stage, Second | 1 | 2012 | 31 | 0.100 |
Why?
|
Sex Counseling | 1 | 2011 | 17 | 0.100 |
Why?
|
Infertility, Male | 1 | 2015 | 409 | 0.100 |
Why?
|
Umbilical Cord | 1 | 2013 | 180 | 0.100 |
Why?
|
Quality of Health Care | 2 | 2016 | 4371 | 0.100 |
Why?
|
Myometrium | 1 | 2013 | 181 | 0.100 |
Why?
|
Labor, Obstetric | 2 | 2016 | 333 | 0.100 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2018 | 780 | 0.100 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3086 | 0.100 |
Why?
|
Perinatology | 1 | 2012 | 57 | 0.100 |
Why?
|
Cholinergic Antagonists | 2 | 2023 | 165 | 0.100 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3022 | 0.100 |
Why?
|
Cardiomyopathies | 2 | 2015 | 1912 | 0.100 |
Why?
|
Public Health Practice | 1 | 2014 | 218 | 0.100 |
Why?
|
Models, Statistical | 2 | 2020 | 5102 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1788 | 0.100 |
Why?
|
Urban Population | 3 | 2017 | 2021 | 0.100 |
Why?
|
South Carolina | 2 | 2022 | 99 | 0.100 |
Why?
|
Single-Blind Method | 4 | 2018 | 1590 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2015 | 550 | 0.100 |
Why?
|
Fetal Death | 3 | 2020 | 448 | 0.100 |
Why?
|
Echocardiography | 2 | 2015 | 5102 | 0.100 |
Why?
|
Aged | 22 | 2023 | 163280 | 0.100 |
Why?
|
Pregnancy Proteins | 1 | 2012 | 229 | 0.100 |
Why?
|
Urologic Surgical Procedures | 1 | 2014 | 302 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2020 | 20822 | 0.100 |
Why?
|
Electronic Mail | 1 | 2013 | 213 | 0.100 |
Why?
|
Sex Preselection | 1 | 2010 | 18 | 0.100 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.090 |
Why?
|
Hydrocortisone | 1 | 2018 | 1826 | 0.090 |
Why?
|
Attitude | 1 | 2015 | 776 | 0.090 |
Why?
|
Defecation | 1 | 2012 | 188 | 0.090 |
Why?
|
Self Care | 1 | 2015 | 786 | 0.090 |
Why?
|
Peritoneum | 1 | 2011 | 228 | 0.090 |
Why?
|
Videotape Recording | 1 | 2012 | 352 | 0.090 |
Why?
|
Bacteriological Techniques | 1 | 2011 | 277 | 0.090 |
Why?
|
Embryo Culture Techniques | 1 | 2010 | 80 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 3229 | 0.090 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.090 |
Why?
|
Urinary Bladder | 1 | 2016 | 1172 | 0.090 |
Why?
|
Bone and Bones | 1 | 2020 | 2575 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 3 | 2021 | 1683 | 0.090 |
Why?
|
Parenting | 1 | 2015 | 679 | 0.090 |
Why?
|
Fecal Incontinence | 3 | 2019 | 239 | 0.090 |
Why?
|
Ovarian Neoplasms | 2 | 2020 | 4838 | 0.090 |
Why?
|
Thigh | 1 | 2010 | 247 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1941 | 0.080 |
Why?
|
Hip | 1 | 2010 | 257 | 0.080 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2011 | 323 | 0.080 |
Why?
|
Shock, Septic | 1 | 2015 | 775 | 0.080 |
Why?
|
Estrogens | 1 | 2016 | 1566 | 0.080 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2017 | 4266 | 0.080 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 634 | 0.080 |
Why?
|
Follicular Fluid | 1 | 2009 | 87 | 0.080 |
Why?
|
Educational Measurement | 1 | 2015 | 1210 | 0.080 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2011 | 324 | 0.080 |
Why?
|
Oogenesis | 1 | 2009 | 131 | 0.080 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 2008 | 53 | 0.080 |
Why?
|
Paracentesis | 1 | 2008 | 95 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2021 | 2282 | 0.080 |
Why?
|
Sarcoma | 1 | 2020 | 1897 | 0.080 |
Why?
|
Decision Trees | 2 | 2021 | 506 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2278 | 0.080 |
Why?
|
Chlamydia Infections | 1 | 2011 | 365 | 0.080 |
Why?
|
Child | 13 | 2023 | 77709 | 0.080 |
Why?
|
Feedback | 1 | 2012 | 795 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2018 | 57776 | 0.080 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7785 | 0.080 |
Why?
|
Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.080 |
Why?
|
Body Mass Index | 5 | 2023 | 12720 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2017 | 2050 | 0.080 |
Why?
|
Surgical Mesh | 3 | 2017 | 276 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2010 | 365 | 0.070 |
Why?
|
Pandemics | 6 | 2023 | 8388 | 0.070 |
Why?
|
Genome, Human | 2 | 2018 | 4420 | 0.070 |
Why?
|
Cytokines | 2 | 2023 | 7322 | 0.070 |
Why?
|
Fetus | 2 | 2019 | 1880 | 0.070 |
Why?
|
Risk Assessment | 7 | 2020 | 23338 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 642 | 0.070 |
Why?
|
Blood Transfusion | 1 | 2013 | 1301 | 0.070 |
Why?
|
Apolipoproteins | 1 | 2009 | 317 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2017 | 3086 | 0.070 |
Why?
|
Constipation | 3 | 2019 | 546 | 0.070 |
Why?
|
Child, Preschool | 8 | 2022 | 41006 | 0.070 |
Why?
|
Vaginal Diseases | 1 | 2007 | 102 | 0.070 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2006 | 18 | 0.070 |
Why?
|
Urodynamics | 2 | 2019 | 347 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 457 | 0.070 |
Why?
|
Surgical Wound Infection | 2 | 2014 | 1540 | 0.070 |
Why?
|
Botswana | 2 | 2021 | 1040 | 0.070 |
Why?
|
Models, Chemical | 1 | 2008 | 626 | 0.070 |
Why?
|
Models, Educational | 1 | 2008 | 377 | 0.070 |
Why?
|
Regional Medical Programs | 1 | 2006 | 71 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8428 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2008 | 311 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3743 | 0.070 |
Why?
|
Documentation | 1 | 2011 | 871 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12354 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2021 | 1150 | 0.060 |
Why?
|
Peritoneal Neoplasms | 1 | 2011 | 665 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2212 | 0.060 |
Why?
|
Factor VIII | 1 | 2007 | 347 | 0.060 |
Why?
|
Tuberculosis | 1 | 2017 | 1912 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5853 | 0.060 |
Why?
|
Clinical Clerkship | 1 | 2010 | 532 | 0.060 |
Why?
|
Axilla | 2 | 2018 | 595 | 0.060 |
Why?
|
CpG Islands | 2 | 2020 | 1172 | 0.060 |
Why?
|
Cost-Benefit Analysis | 4 | 2021 | 5391 | 0.060 |
Why?
|
Women's Health | 3 | 2024 | 2034 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Sheep | 2 | 2008 | 1437 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2461 | 0.060 |
Why?
|
Poisson Distribution | 2 | 2016 | 513 | 0.060 |
Why?
|
Collagen | 2 | 2003 | 2689 | 0.060 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1151 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5985 | 0.060 |
Why?
|
Orgasm | 1 | 2024 | 64 | 0.060 |
Why?
|
HIV Infections | 2 | 2021 | 16718 | 0.060 |
Why?
|
Preoperative Period | 2 | 2016 | 549 | 0.060 |
Why?
|
Self Report | 3 | 2020 | 3558 | 0.060 |
Why?
|
Adenoviridae | 1 | 2008 | 1099 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2016 | 2425 | 0.060 |
Why?
|
Fetal Growth Retardation | 2 | 2020 | 570 | 0.060 |
Why?
|
Soaps | 1 | 2023 | 28 | 0.060 |
Why?
|
Protein S | 1 | 2002 | 30 | 0.060 |
Why?
|
Fetal Macrosomia | 2 | 2015 | 124 | 0.060 |
Why?
|
Joint Diseases | 1 | 2007 | 480 | 0.060 |
Why?
|
Elbow Joint | 1 | 2007 | 357 | 0.050 |
Why?
|
Gastric Bypass | 1 | 2011 | 812 | 0.050 |
Why?
|
Mastectomy, Segmental | 2 | 2019 | 956 | 0.050 |
Why?
|
Ankle Joint | 1 | 2007 | 411 | 0.050 |
Why?
|
Sex Education | 2 | 2014 | 93 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2022 | 26 | 0.050 |
Why?
|
Diethylstilbestrol | 1 | 2022 | 93 | 0.050 |
Why?
|
Prognosis | 6 | 2021 | 29063 | 0.050 |
Why?
|
Halogenated Diphenyl Ethers | 1 | 2022 | 77 | 0.050 |
Why?
|
Severity of Illness Index | 6 | 2017 | 15540 | 0.050 |
Why?
|
Radiotherapy | 2 | 2020 | 1533 | 0.050 |
Why?
|
Hospital Mortality | 1 | 2016 | 5317 | 0.050 |
Why?
|
Blood Platelets | 2 | 2003 | 2508 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1701 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2171 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.050 |
Why?
|
Ligaments | 1 | 2022 | 128 | 0.050 |
Why?
|
Transcription Factors | 2 | 2020 | 12208 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5751 | 0.050 |
Why?
|
Perinatal Mortality | 1 | 2022 | 105 | 0.050 |
Why?
|
Reference Values | 2 | 2007 | 4982 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.050 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2635 | 0.050 |
Why?
|
Beta Particles | 1 | 2021 | 50 | 0.050 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2001 | 69 | 0.050 |
Why?
|
Image Enhancement | 1 | 2012 | 2921 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2073 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.050 |
Why?
|
DNA, Viral | 1 | 2008 | 2225 | 0.050 |
Why?
|
Health Status Indicators | 1 | 2007 | 969 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11524 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2007 | 2274 | 0.050 |
Why?
|
Hysterectomy, Vaginal | 1 | 2020 | 37 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13695 | 0.050 |
Why?
|
Synovitis | 1 | 2002 | 209 | 0.050 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7279 | 0.050 |
Why?
|
Chickenpox | 1 | 2001 | 131 | 0.050 |
Why?
|
Birth Certificates | 1 | 2020 | 67 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7729 | 0.050 |
Why?
|
Observer Variation | 1 | 2007 | 2593 | 0.050 |
Why?
|
Postmenopause | 2 | 2022 | 2461 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11031 | 0.050 |
Why?
|
Herpesvirus 3, Human | 1 | 2001 | 204 | 0.050 |
Why?
|
Medically Underserved Area | 1 | 2022 | 253 | 0.050 |
Why?
|
Communication Barriers | 1 | 2023 | 398 | 0.050 |
Why?
|
Curriculum | 3 | 2023 | 3605 | 0.050 |
Why?
|
Vitrification | 1 | 2020 | 56 | 0.050 |
Why?
|
Weight Loss | 1 | 2011 | 2622 | 0.050 |
Why?
|
Recovery of Function | 2 | 2020 | 2925 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 2 | 2014 | 215 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2012 | 3821 | 0.040 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.040 |
Why?
|
Apgar Score | 1 | 2019 | 123 | 0.040 |
Why?
|
Intention | 1 | 2022 | 341 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2003 | 582 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15076 | 0.040 |
Why?
|
Depressive Disorder, Major | 2 | 2015 | 4644 | 0.040 |
Why?
|
Stroke Volume | 1 | 2012 | 5007 | 0.040 |
Why?
|
Cross Reactions | 1 | 2021 | 841 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6364 | 0.040 |
Why?
|
Cell Shape | 1 | 2020 | 375 | 0.040 |
Why?
|
Logistic Models | 4 | 2019 | 13408 | 0.040 |
Why?
|
Obesity | 2 | 2022 | 12745 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2018 | 2187 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2002 | 541 | 0.040 |
Why?
|
Probability | 3 | 2012 | 2505 | 0.040 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1060 | 0.040 |
Why?
|
ROC Curve | 2 | 2019 | 3527 | 0.040 |
Why?
|
Freezing | 1 | 2019 | 303 | 0.040 |
Why?
|
Anger | 1 | 2020 | 402 | 0.040 |
Why?
|
Educational Status | 2 | 2017 | 2540 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.040 |
Why?
|
Term Birth | 1 | 2018 | 135 | 0.040 |
Why?
|
Uterus | 1 | 2022 | 711 | 0.040 |
Why?
|
Knee Joint | 1 | 2007 | 1680 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2018 | 2585 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2002 | 1092 | 0.040 |
Why?
|
Maternal-Child Health Centers | 1 | 2017 | 40 | 0.040 |
Why?
|
Hemorrhage | 2 | 2007 | 3461 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.040 |
Why?
|
Immunoassay | 1 | 2021 | 752 | 0.040 |
Why?
|
Chorionic Villi | 1 | 2017 | 51 | 0.040 |
Why?
|
Pain Measurement | 2 | 2020 | 3420 | 0.040 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2021 | 387 | 0.040 |
Why?
|
Markov Chains | 1 | 2021 | 969 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2023 | 1200 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1402 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14722 | 0.040 |
Why?
|
Mycobacterium bovis | 1 | 2017 | 150 | 0.040 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2016 | 29 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 365 | 0.040 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2002 | 2726 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12245 | 0.040 |
Why?
|
Comprehension | 2 | 2012 | 610 | 0.040 |
Why?
|
Laparotomy | 1 | 2019 | 473 | 0.040 |
Why?
|
Watchful Waiting | 1 | 2021 | 492 | 0.040 |
Why?
|
Blood Proteins | 1 | 2001 | 1124 | 0.030 |
Why?
|
Acetaminophen | 1 | 2020 | 545 | 0.030 |
Why?
|
Vaginal Discharge | 1 | 2016 | 25 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
Israel | 1 | 2019 | 796 | 0.030 |
Why?
|
Nocturia | 1 | 2016 | 19 | 0.030 |
Why?
|
Administration, Intravaginal | 1 | 2016 | 150 | 0.030 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2016 | 119 | 0.030 |
Why?
|
Hair | 1 | 2018 | 483 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2018 | 553 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 689 | 0.030 |
Why?
|
Democratic Republic of the Congo | 1 | 2015 | 88 | 0.030 |
Why?
|
Health Literacy | 1 | 2020 | 414 | 0.030 |
Why?
|
Models, Biological | 2 | 2008 | 9583 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 903 | 0.030 |
Why?
|
Medicare | 2 | 2023 | 6566 | 0.030 |
Why?
|
Organizational Culture | 1 | 2018 | 510 | 0.030 |
Why?
|
Sudan | 1 | 2014 | 83 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2018 | 600 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2018 | 703 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1318 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 2016 | 255 | 0.030 |
Why?
|
Parturition | 1 | 2018 | 441 | 0.030 |
Why?
|
Triage | 1 | 2021 | 976 | 0.030 |
Why?
|
Medical Staff | 1 | 2014 | 43 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.030 |
Why?
|
Nurse's Role | 1 | 2016 | 209 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2016 | 711 | 0.030 |
Why?
|
Quality of Life | 3 | 2023 | 12804 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.030 |
Why?
|
HIV | 1 | 2021 | 1604 | 0.030 |
Why?
|
Fetal Weight | 1 | 2013 | 80 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10180 | 0.030 |
Why?
|
Constriction | 1 | 2013 | 181 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 744 | 0.030 |
Why?
|
Midwifery | 1 | 2015 | 132 | 0.030 |
Why?
|
Choice Behavior | 1 | 2019 | 803 | 0.030 |
Why?
|
New York | 1 | 2016 | 886 | 0.030 |
Why?
|
Schools, Medical | 1 | 2020 | 880 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2065 | 0.030 |
Why?
|
Aging | 2 | 2009 | 8664 | 0.030 |
Why?
|
Autoantibodies | 1 | 2001 | 2035 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2016 | 13989 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7880 | 0.030 |
Why?
|
Proctocolectomy, Restorative | 1 | 2014 | 189 | 0.030 |
Why?
|
Students | 1 | 2022 | 1654 | 0.030 |
Why?
|
Pregnancy in Adolescence | 1 | 2014 | 158 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2016 | 1005 | 0.030 |
Why?
|
Cystocele | 1 | 2012 | 5 | 0.030 |
Why?
|
Sutures | 1 | 2014 | 299 | 0.030 |
Why?
|
Spouses | 1 | 2015 | 286 | 0.030 |
Why?
|
Antigens, CD | 1 | 2003 | 4026 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 441 | 0.030 |
Why?
|
Environmental Monitoring | 1 | 2019 | 1414 | 0.030 |
Why?
|
Urban Health Services | 1 | 2013 | 179 | 0.030 |
Why?
|
Rectocele | 1 | 2012 | 22 | 0.030 |
Why?
|
Bromocriptine | 1 | 2012 | 111 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2013 | 552 | 0.030 |
Why?
|
Population Surveillance | 2 | 2014 | 2616 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.030 |
Why?
|
Hematocrit | 1 | 2013 | 636 | 0.030 |
Why?
|
Research Design | 2 | 2020 | 5987 | 0.030 |
Why?
|
Hernia | 1 | 2012 | 71 | 0.030 |
Why?
|
Mother-Child Relations | 1 | 2015 | 481 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5952 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2043 | 0.030 |
Why?
|
Leiomyoma | 1 | 2017 | 730 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 2011 | 419 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1584 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4201 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1770 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 426 | 0.020 |
Why?
|
Birth Injuries | 1 | 2012 | 148 | 0.020 |
Why?
|
Individuality | 1 | 2012 | 307 | 0.020 |
Why?
|
Poverty | 1 | 2022 | 2660 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2016 | 687 | 0.020 |
Why?
|
Brachial Plexus | 1 | 2012 | 163 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2282 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1341 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 781 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2022 | 13033 | 0.020 |
Why?
|
Disease Progression | 1 | 2007 | 13284 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2924 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.020 |
Why?
|
Neural Tube Defects | 1 | 2012 | 256 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6538 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1198 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1656 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 2020 | 0.020 |
Why?
|
Platelet Aggregation | 2 | 2003 | 798 | 0.020 |
Why?
|
Mastectomy | 1 | 2018 | 1793 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3508 | 0.020 |
Why?
|
Coagulation Protein Disorders | 1 | 2008 | 7 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2012 | 414 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 2988 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4397 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
Platelet Activation | 2 | 2003 | 673 | 0.020 |
Why?
|
Medicaid | 1 | 2022 | 2736 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2021 | 2071 | 0.020 |
Why?
|
Patient Participation | 1 | 2018 | 1457 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 426 | 0.020 |
Why?
|
California | 1 | 2013 | 1402 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2400 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2576 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.020 |
Why?
|
Coronary Disease | 1 | 2003 | 6077 | 0.020 |
Why?
|
Community Health Services | 1 | 2013 | 650 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2018 | 2416 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2013 | 1240 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2016 | 1524 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3479 | 0.020 |
Why?
|
Preoperative Care | 1 | 2017 | 2250 | 0.020 |
Why?
|
Prolapse | 1 | 2007 | 68 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2013 | 624 | 0.020 |
Why?
|
Chromosomes, Human, Y | 1 | 2008 | 148 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2012 | 556 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 2539 | 0.020 |
Why?
|
Workflow | 1 | 2011 | 847 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Molecular Weight | 1 | 2009 | 2255 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2008 | 296 | 0.020 |
Why?
|
Thermodynamics | 1 | 2008 | 596 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 35421 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2012 | 1206 | 0.020 |
Why?
|
Medical Records | 1 | 2011 | 1413 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3507 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2010 | 853 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4986 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2015 | 1248 | 0.020 |
Why?
|
Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12026 | 0.020 |
Why?
|
Minority Groups | 1 | 2013 | 1223 | 0.020 |
Why?
|
Hospitals, University | 1 | 2007 | 571 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15165 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1351 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2008 | 691 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2017 | 3748 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9438 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8642 | 0.010 |
Why?
|
Ovary | 1 | 2008 | 981 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.010 |
Why?
|
Paclitaxel | 1 | 2011 | 1708 | 0.010 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.010 |
Why?
|
Internal Medicine | 1 | 2011 | 1009 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 2003 | 326 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2012 | 1637 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 2002 | 104 | 0.010 |
Why?
|
Forecasting | 1 | 2012 | 2951 | 0.010 |
Why?
|
Receptor Cross-Talk | 1 | 2003 | 119 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5078 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1119 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11483 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.010 |
Why?
|
Trans-Activators | 1 | 2012 | 2924 | 0.010 |
Why?
|
Elbow | 1 | 2002 | 138 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2011 | 2057 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2647 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2008 | 1783 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18029 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1813 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3508 | 0.010 |
Why?
|
Knee | 1 | 2002 | 274 | 0.010 |
Why?
|
Outpatients | 1 | 2008 | 1486 | 0.010 |
Why?
|
Obesity, Morbid | 1 | 2011 | 1213 | 0.010 |
Why?
|
Animals | 4 | 2021 | 168757 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1972 | 0.010 |
Why?
|
Decision Making | 1 | 2013 | 3887 | 0.010 |
Why?
|
Primary Health Care | 1 | 2016 | 4558 | 0.010 |
Why?
|
Ankle | 1 | 2002 | 327 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4933 | 0.010 |
Why?
|
Binding Sites | 1 | 2008 | 6114 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 6038 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4467 | 0.010 |
Why?
|
Angina, Unstable | 1 | 2002 | 926 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14557 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4409 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10943 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2001 | 1127 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2001 | 2373 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2003 | 5974 | 0.010 |
Why?
|
Mice | 1 | 2012 | 81183 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2002 | 11727 | 0.000 |
Why?
|
Stroke | 1 | 2002 | 9981 | 0.000 |
Why?
|